CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate how safe and how well an investigational imaging product
CardioPET™ performs as compared to standard approved imaging products in assessing the
function of heart muscle in coronary artery disease patients.